Fitzpatrick A, Shanmugalingam T, Haider S, Maruzani R, et al. Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease. Clin Cancer Res 2026 Oct 13. doi: 10.1158/1078-0432.CCR-26-1885.
PMID: 42868273